新发现的益生菌Lactobacillus reuteri LY2-2对DSS诱导的大肠炎的保护作用
Yong Yang1,2, Yuyu Qiao2, Ge Liu2
1School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, 030001, China.
European journal of nutrition
|November 15, 2024
概括
这项研究表明,益生菌*Lactobacillus reuteri* LY2-2通过减少炎症和平衡肠道细菌,有效治疗小鼠的大肠炎. 它为炎症性肠病的传统治疗提供了一个有希望的替代方案.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠病 (IBD),特别是大肠炎,对健康构成重大挑战.
- 目前治疗大肠炎的方法有局限性和副作用.
- 益生菌正在成为IBD的潜在治疗策略.
研究的目的:
- 在小鼠模型中研究一种新的*Lactobacillus reuteri*菌株LY2-2对硫酸 (DSS) 诱导的大肠炎的治疗效果.
- 阐明 *L. reuteri* LY2-2 发挥其保护作用的基本机制.
主要方法:
- *Lactobacillus reuteri* LY2-2被口服给患有DSS诱导的大肠炎的小鼠.
- 用5-氨基酸 (5-ASA) 作为阳性对照进行比较.
- 评估了疾病严重程度,肠道炎症,免疫反应,肠道屏障功能和肠道微生物群组成.
主要成果:
- *L. reuteri* LY2-2显著减轻了结肠炎的严重程度和减少了肠道炎症.
- 用LY2-2治疗抑制了促炎性细胞因子和TLR4-NF-κB信号通路.
- LY2-2调节了巨细胞极化,增强了肠道屏障功能,改善了肠道失生症,增加了有益的细菌,同时减少了致病性细菌.
- LY2-2的治疗效果优于5-ASA的治疗效果.
结论:
- *L. reuteri* LY2-2通过抗炎和微生物群平衡机制,显示出对DSS诱导的大肠炎的显著保护作用.
- 这种菌株显示出作为治疗大肠炎的功能益生菌的潜力.
- 这些发现支持*L. reuteri* LY2-2用于结肠炎治疗的发展,并提供了对其影响人类健康的生物功能的见解.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.2K
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
805
相关概念视频
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...